Success Metrics

Clinical Success Rate
80.4%

Based on 111 completed trials

Completion Rate
80%(111/138)
Active Trials
25(10%)
Results Posted
36%(40 trials)
Terminated
27(11%)

Phase Distribution

Ph phase_1
26
11%
Ph phase_4
24
10%
Ph phase_2
71
29%
Ph early_phase_1
12
5%
Ph not_applicable
76
31%
Ph phase_3
32
13%

Phase Distribution

38

Early Stage

71

Mid Stage

56

Late Stage

Phase Distribution241 total trials
Early Phase 1First-in-human
12(5.0%)
Phase 1Safety & dosage
26(10.8%)
Phase 2Efficacy & side effects
71(29.5%)
Phase 3Large-scale testing
32(13.3%)
Phase 4Post-market surveillance
24(10.0%)
N/ANon-phased studies
76(31.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

72.5%

111 of 153 finished

Non-Completion Rate

27.5%

42 ended early

Currently Active

25

trials recruiting

Total Trials

243

all time

Status Distribution
Active(40)
Completed(111)
Terminated(42)
Other(50)

Detailed Status

Completed111
unknown49
Terminated27
Recruiting19
Withdrawn15
Not yet recruiting14

Development Timeline

Analytics

Development Status

Total Trials
243
Active
25
Success Rate
80.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 112 (5.0%)
Phase 126 (10.8%)
Phase 271 (29.5%)
Phase 332 (13.3%)
Phase 424 (10.0%)
N/A76 (31.5%)

Trials by Status

recruiting198%
withdrawn156%
unknown4920%
completed11146%
enrolling_by_invitation10%
terminated2711%
not_yet_recruiting146%
suspended10%
active_not_recruiting62%

Recent Activity

Clinical Trials (243)

Showing 20 of 243 trialsScroll for more
NCT00097474Phase 2

Effects of Hydrocortisone, Melatonin, and Placebo on Jet Lag

Completed
NCT07503600Phase 3

The Effect of Adjunctive Melatonin With Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections

Not Yet Recruiting
NCT05713877Phase 2

Melatonin for Treatment of Delirium in Critically Ill Adult Patients

Recruiting
NCT07472075Phase 2

Melatonin Versus Placebo for Bipolar Disorder

Not Yet Recruiting
NCT07475156Phase 4

The Effect of Dexmedetomidine Infusion Alone Versus the Combination of Dexmedetomidine and Melatonin on Reduction of Post-operative Delirium (POD) After Open Brain Surgeries

Completed
NCT03540485Phase 1

Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis

Terminated
NCT07336277Phase 3

Sleep Quality and the Efficacy of a Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients

Not Yet Recruiting
NCT02642640Not Applicable

Interaction of Melatonin and MTNR1B Genotype on Glucose Control - Study 1

Completed
NCT04588233Not Applicable

Melatonin Adolescent Research Study

Recruiting
NCT07375342Not Applicable

Melatonin for Post Tonsillectomy Emergence Agitation in Pediatric

Enrolling By Invitation
NCT07369284Phase 2

Melatonin for Glycemic Control in Gestational Diabetes Mellitus

Not Yet Recruiting
NCT06404086Phase 2

RECOVER-SLEEP: Platform Protocol

Completed
NCT06404112Phase 2

RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD)

Active Not Recruiting
NCT07305350Phase 2

EFFICACY OF MELATONIN IN MANAGEMENT OF HYPOXIC ISCHEMIC ENCEPHALOPATHY (HIE) IN NEONATES

Active Not Recruiting
NCT05084196Phase 3

Melatonin for Prevention of Kidney Injury

Recruiting
NCT06012175Not Applicable

Melatonin for Knee Osteoarthritis Patients

Completed
NCT05474846Phase 2

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

Recruiting
NCT07221968Phase 2

Melatonin for the Treatment of DEE-SWAS

Not Yet Recruiting
NCT06226025Phase 2

Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder

Recruiting
NCT00262470Phase 1

Treatment of Orthostatic Intolerance

Active Not Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
243